TREA

79261502 - HUGEL

Follow

Information

  • Trademark
  • 79261502
  • Serial Number
    79261502
  • Filing Date
    May 02, 2019
    6 years ago
  • Transaction Date
    March 15, 2025
    2 months ago
  • Status Date
    March 02, 2020
    5 years ago
  • Location Date
    March 02, 2020
    5 years ago
  • Status Code
    602
  • Current Location
    LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    LAMONT, MIAH
  • Law Office Assigned Location Code
    M80
  • Owners
Information
Mark Drawing Code
4
Mark Identification
HUGEL
Case File Statements
  • GS0051: Pharmaceutical and veterinary preparations for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases, and skin disorders; drugs for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes, namely, pharmaceutical preparations comprising botulinum toxin, fragments of botulinum toxin; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating dystonia; pharmaceutical preparations for the treatment of wrinkles; pharmaceutical preparations for the treatment of spasm; pharmaceutical preparations for the treatment of pain; pharmaceutical agents for treating physically caused lesions; pharmaceutical preparations for use in treating urogenital system diseases and conditions; ophthalmic preparations; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for dental purposes; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; microorganisms for medical purposes; cultures of microorganisms for medical or veterinary use; bacteriological preparations for medical and veterinary use; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases, and skin disorders; botulinum toxin for medical use for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases, and skin disorders; appetite suppressants for medical purposes; medicated lotions for treating dermatological conditions; ointments for pharmaceutical purposes; analgesics; pharmaceutical agents affecting peripheral nervous system; bacterial poisons; vaccines; hyaluronic acid mixed with its derivatives and other polysaccharides, including or not including lidocaine, in ampoule form for medical purposes; pharmaceutical preparations mainly based on hyaluronic acid; medical gels for activation of tissues, namely, medical gels for hypodermic syringes for improving wrinkles; hyaluronic acid preparations for medical purposes, namely, fillers for skin and soft tissue used for skin moisturizing and improving wrinkles; modified hyaluronic acid preparations for medical purposes, namely, fillers for skin and soft tissue used for skin moisturizing and improving wrinkles; injectable dermal fillers; pre-filled syringes for medical purposes, namely, prefilled with pharmaceutical preparations in the nature of hyaluronic acid, modified hyaluronic acid, its derivatives or substances that have a similar effect to hyaluronic acid, for the treatment and management of skin and soft tissue or artificial prostheses
  • GS0101: Medical apparatus and instruments; medical apparatus; surgical apparatus and instruments for medical, dental or veterinary use; medical apparatus and instruments for plastic surgery; medical apparatus and instruments for the treatment of skin; sutures; suture for medical purpose; syringes for medical purposes and for injections; medical filler apparatus; medical filler syringes; dermatoplastic instruments; surgical instruments for use in cosmetic surgery and plastic surgery for skin; skin esthetic massaging apparatus; orthopaedic articles; dental apparatus and instruments; gloves for use in hospitals; masks for medical purposes; dermic implants for medical use, intended for filling of wrinkles or increasing volume; syringes for injecting medical substances for the skin, namely, used for the injection of hyaluronic acid for contouring lips and faces, scar correction and wrinkle reduction for medical purposes
Case File Event Statements
  • 6/20/2019 - 5 years ago
    1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC
  • 6/29/2019 - 5 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 7/23/2019 - 5 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/23/2019 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/24/2019 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/27/2019 - 5 years ago
    7 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 8/20/2019 - 5 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 8/20/2019 - 5 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 9/6/2019 - 5 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/2/2020 - 5 years ago
    11 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 3/2/2020 - 5 years ago
    12 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 11/25/2020 - 4 years ago
    13 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 11/25/2020 - 4 years ago
    14 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/12/2020 - 4 years ago
    15 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 3/2/2021 - 4 years ago
    17 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 3/21/2021 - 4 years ago
    18 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINT
  • 2/14/2025 - 3 months ago
    19 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 3/14/2025 - 2 months ago
    20 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 3/2/2021 - 4 years ago
    16 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 7/25/2019 - 5 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR